YB

YB
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $1.07B ▲ | $731.294M ▲ | $304.691M ▲ | 28.478% ▼ | $164.13 ▲ | $297.732M ▲ |
| Q1-2025 | $970.056M ▲ | $635.888M ▲ | $295.102M ▲ | 30.421% ▼ | $42.11 ▼ | $289.412M ▼ |
| Q4-2024 | $888.757M ▲ | $556.972M ▼ | $292.299M ▲ | 32.889% ▲ | $83.2 ▲ | $293.077M ▲ |
| Q3-2024 | $866.776M ▲ | $567.573M ▼ | $244.839M ▲ | 28.247% ▲ | $-11.7 ▼ | $258.299M ▲ |
| Q2-2024 | $854.456M | $624.753M | $195.857M | 22.922% | $14.16 | $188.912M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $3.404B ▲ | $3.905B ▲ | $1.297B ▼ | $2.608B ▲ |
| Q1-2025 | $2.752B ▲ | $3.248B ▲ | $4.549B ▲ | $-1.3B ▲ |
| Q4-2024 | $2.321B ▲ | $2.78B ▲ | $4.413B ▲ | $-1.634B ▲ |
| Q3-2024 | $2.042B ▲ | $2.426B ▲ | $4.281B ▲ | $-1.855B ▲ |
| Q2-2024 | $1.702B | $2.171B | $4.101B | $-1.93B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $292.299M ▲ | $277.187M ▼ | $-153.436M ▼ | $-6.313M ▼ | $125.096M ▼ | $276.852M ▼ |
| Q3-2024 | $244.839M ▲ | $348.838M ▲ | $121.09M ▲ | $-2.8M ▼ | $464.354M ▲ | $348.107M ▲ |
| Q4-2023 | $89.22M ▲ | $161.53M ▲ | $-11.328M ▼ | $0 | $168.296M ▲ | $161.492M ▲ |
| Q3-2023 | $43.444M ▲ | $17.711M ▼ | $-2.43M ▼ | $0 | $24.4M ▼ | $16.331M ▼ |
| Q4-2022 | $13.422M | $68.226M | $2.598M | $0 | $68.152M | $67.832M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, Yuanbao looks like a fast‑growing, technology‑driven insurance distributor that has successfully crossed the line from loss‑making startup to profitable operator. Revenue growth, rising margins, strong cash generation, and low debt all paint a positive operational picture, while negative equity and dependence on continued high growth and strong partnerships are the main financial and strategic flags to study. The company’s competitive edge is tied closely to its AI and data capabilities and its carrier relationships in China’s online insurance market. Going forward, the key questions are whether it can sustain high profitability as it scales, navigate regulatory and competitive pressures, and continue turning heavy investment in technology and innovation into durable, cash‑backed results.
About Yuanbao Inc. American Depositary Shares
https://www.yuanbaobaoxian.cnYuanbao Inc., through its subsidiaries, provides online insurance distribution and services in the People's Republic of China. The company offers medical, critical illness, life, and other insurance products. It also provides system services, including precise marketing, analytics, and other system services.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q2-2025 | $1.07B ▲ | $731.294M ▲ | $304.691M ▲ | 28.478% ▼ | $164.13 ▲ | $297.732M ▲ |
| Q1-2025 | $970.056M ▲ | $635.888M ▲ | $295.102M ▲ | 30.421% ▼ | $42.11 ▼ | $289.412M ▼ |
| Q4-2024 | $888.757M ▲ | $556.972M ▼ | $292.299M ▲ | 32.889% ▲ | $83.2 ▲ | $293.077M ▲ |
| Q3-2024 | $866.776M ▲ | $567.573M ▼ | $244.839M ▲ | 28.247% ▲ | $-11.7 ▼ | $258.299M ▲ |
| Q2-2024 | $854.456M | $624.753M | $195.857M | 22.922% | $14.16 | $188.912M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q2-2025 | $3.404B ▲ | $3.905B ▲ | $1.297B ▼ | $2.608B ▲ |
| Q1-2025 | $2.752B ▲ | $3.248B ▲ | $4.549B ▲ | $-1.3B ▲ |
| Q4-2024 | $2.321B ▲ | $2.78B ▲ | $4.413B ▲ | $-1.634B ▲ |
| Q3-2024 | $2.042B ▲ | $2.426B ▲ | $4.281B ▲ | $-1.855B ▲ |
| Q2-2024 | $1.702B | $2.171B | $4.101B | $-1.93B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q4-2024 | $292.299M ▲ | $277.187M ▼ | $-153.436M ▼ | $-6.313M ▼ | $125.096M ▼ | $276.852M ▼ |
| Q3-2024 | $244.839M ▲ | $348.838M ▲ | $121.09M ▲ | $-2.8M ▼ | $464.354M ▲ | $348.107M ▲ |
| Q4-2023 | $89.22M ▲ | $161.53M ▲ | $-11.328M ▼ | $0 | $168.296M ▲ | $161.492M ▲ |
| Q3-2023 | $43.444M ▲ | $17.711M ▼ | $-2.43M ▼ | $0 | $24.4M ▼ | $16.331M ▼ |
| Q4-2022 | $13.422M | $68.226M | $2.598M | $0 | $68.152M | $67.832M |
Five-Year Company Overview
Income Statement

Balance Sheet

Cash Flow

Competitive Edge

Innovation and R&D

Summary
Overall, Yuanbao looks like a fast‑growing, technology‑driven insurance distributor that has successfully crossed the line from loss‑making startup to profitable operator. Revenue growth, rising margins, strong cash generation, and low debt all paint a positive operational picture, while negative equity and dependence on continued high growth and strong partnerships are the main financial and strategic flags to study. The company’s competitive edge is tied closely to its AI and data capabilities and its carrier relationships in China’s online insurance market. Going forward, the key questions are whether it can sustain high profitability as it scales, navigate regulatory and competitive pressures, and continue turning heavy investment in technology and innovation into durable, cash‑backed results.

CEO
Rui Fang
Compensation Summary
(Year 2024)

CEO
Rui Fang
Compensation Summary
(Year 2024)
Ratings Snapshot
Rating : A

